Losartan Overdose and Accidental Excess Dose: Recognition, Treatment, and Clinical Management

At a glance

  • Drug class / angiotensin II receptor blocker (ARB)
  • Adult hypertension dose ceiling / 100 mg once daily in the Cozaar label, not an overdose safety threshold
  • Main overdose concern / low blood pressure, with a fast or sometimes slow pulse
  • Hemodialysis / does not remove losartan or its active metabolite
  • Evidence base / limited human overdose data and small mixed-ARB case series
  • Activated charcoal / selective medical use, not routine treatment
  • Poison Control / 1-800-222-1222 in the United States

How Losartan Works: Mechanism Behind Overdose Effects

Losartan and its active metabolite block the AT1 receptor through which angiotensin II constricts blood vessels and stimulates aldosterone release. Excess exposure can therefore interfere with blood-pressure regulation. This mechanism describes why hypotension is plausible; it cannot predict an individual's response from tablet count alone 1.

A human pharmacokinetic study describes losartan's conversion to the longer-lasting metabolite EXP3174 2. Drug concentration, receptor activity and clinical symptoms are different measurements. A therapeutic pharmacokinetic experiment does not establish an overdose threshold or discharge time.

Recognizing Losartan Overdose: Symptoms and Clinical Presentation

The Cozaar label identifies hypotension and tachycardia as likely overdose manifestations; bradycardia is also possible. Kidney function and potassium deserve attention, especially where renal disease, volume depletion or interacting medicines are present 1.

The most relevant poison-center series included 206 single-drug ARB exposures, of which 26 involved losartan. It collected cases from eight centers in Austria, Germany and Switzerland. Among 150 children, 82.7% were asymptomatic and 16.7% had minor symptoms. Among 56 adults, 53.6% were asymptomatic, 37.5% had minor symptoms and 8.9% had moderate symptoms 3.

Those are class-wide results from selected cases with a known dose and follow-up. They are not losartan-specific rates, a U.S. national survey or a guarantee that an extra tablet is harmless. The study's weight-adjusted dose analysis also cannot be reduced to one tablet-count rule for every patient.

Emergency Treatment Protocol for Losartan Overdose

Treatment is guided by the actual exposure and clinical findings. The label calls for supportive treatment when symptomatic hypotension develops 1. The ARB case series documents one child who required intravenous fluids after a candesartan ingestion, not a validated losartan-specific resuscitation algorithm 3.

Activated charcoal has a narrower role than a routine overdose remedy. The toxicology position paper recommends considering it selectively after a potentially toxic ingestion of a substance it can adsorb, especially within one hour. Later benefit cannot be excluded, but clinical outcome benefit has not been demonstrated. An intact or protected airway is essential 4.

The available evidence does not supply a universal losartan vasopressor dose, blood-pressure target, potassium treatment trigger or laboratory schedule. A sepsis treatment protocol addresses a different disease process and is not evidence for those instructions in isolated losartan poisoning.

The Role of Hemodialysis in Losartan Overdose

The prescribing information states that hemodialysis removes neither losartan nor its active metabolite 1. Dialysis for a separate kidney complication or another ingested substance is a different clinical question. It should not be described as a losartan-clearing antidote.

Accidental Double Doses and Therapeutic Excess

An extra dose needs assessment in the context of the prescribed regimen, tablet strength, time taken, other medicines and current symptoms. Poison Control provides exposure-specific guidance 5. Keep those details available when calling.

The labeled adult hypertension maximum is a treatment dose, not proof that 200 mg is safe. Likewise, studies of planned therapeutic dosing cannot justify a blanket instruction to skip the next dose and resume the following day. Advice about the next scheduled dose should be part of the assessment of the dosing error.

Pediatric Considerations in Losartan Overdose

A prospective Australian poison-center study followed 19 childhood ingestions involving ACE inhibitors or ARBs. Ten were ARB exposures. Most children remained asymptomatic, but the authors found the ARB dose threshold for observation less clear than for ACE inhibitors 6.

The larger mixed-ARB series also contained children, including the toddler who required fluids after candesartan exposure 3. Neither study establishes that every child can stay home after one tablet or must attend an emergency department after two. Poison Control can assess the exact product, strength, child's weight and circumstances 5.

Drug Interactions That Amplify Overdose Risk

Other blood-pressure-lowering drugs, potassium-raising medicines, NSAIDs and dual renin-angiotensin-system treatment can change the clinical assessment. The label documents concerns involving potassium, renal function and hypotension 1.

A community study linked NSAID use with diuretics and/or renin-angiotensin-system inhibitors to increased acute kidney injury risk 7. It studied routine medicine use, not a losartan overdose treatment protocol. Drug interactions should not be presented as protective simply because they alter metabolite formation.

Monitoring Timeline and Disposition

The small exposure studies do not validate one observation duration or repeat-laboratory timetable for every losartan ingestion. Their population and outcome limits matter when deciding whether results apply to a particular exposure 3 6.

An asymptomatic accidental dosing error, symptomatic poisoning and an ingestion involving several cardiovascular medicines are different situations. The assessment determines monitoring, any blood tests and discharge timing. Pharmacokinetic half-lives alone do not establish how long overdose symptoms will last.

Losartan's Safety Profile in Context: LIFE Trial and Therapeutic Index

LIFE was a randomized comparison of losartan-based and atenolol-based hypertension treatment in 9,193 people with left ventricular hypertrophy. It examined cardiovascular outcomes during prescribed treatment 8.

A therapeutic trial and a poison-center exposure series answer different questions. LIFE does not prove that a large accidental or intentional dose is safe, and the small mixed-ARB series cannot establish a reliable losartan fatality rate.

When to Call 911 vs. Poison Control

Poison Control advises calling 911 when someone collapses, has a seizure or cannot be awakened. For an extra dose or uncertain ingestion without those emergency signs, call 1-800-222-1222 for case-specific guidance 5. A home blood-pressure number by itself does not resolve every ingestion question.

Frequently asked questions

What happens if you take too much losartan?
Blood pressure can fall and heart rate can change. Effects depend on the exposure and other medicines; call Poison Control for an individual assessment.
How much losartan is considered an overdose?
An amount above the prescribed dose is a dosing excess. The labeled hypertension maximum is not a toxicity threshold; tablet count alone cannot determine the outcome.
Is there an antidote for losartan overdose?
The prescribing information describes supportive treatment rather than a specific antidote. Treatment decisions depend on the clinical findings.
Can hemodialysis remove losartan from the body?
No. The Cozaar label states that hemodialysis does not remove losartan or its active metabolite.
What should I do if I accidentally took two losartan pills?
Call Poison Control at 1-800-222-1222 with the tablet strength, timing, prescribed dose and other medicines. Get advice about the next dose for that exposure.
How does losartan work in the body?
Losartan and its active metabolite block angiotensin II at the AT1 receptor, reducing its blood-pressure-raising effects.
How long do losartan overdose symptoms last?
The cited studies do not establish one symptom duration. Drug half-life alone cannot determine the observation period or discharge time.
Is losartan overdose fatal?
The available small exposure studies cannot establish a reliable losartan fatality rate. They should not be used to declare a particular overdose harmless.
Can children die from taking a losartan pill?
Tablet count alone cannot establish a child's risk. Call Poison Control with the exact product, strength, child's weight and circumstances.
What medications make losartan overdose more dangerous?
Other antihypertensives, potassium-raising medicines, NSAIDs and other renin-angiotensin-system drugs can complicate assessment. Report the complete medicine list to Poison Control.
Should I go to the ER for a losartan overdose?
Call 911 for collapse, seizure or inability to awaken. Otherwise Poison Control can assess the ingestion and direct the appropriate level of care.
Does activated charcoal work for losartan overdose?
Charcoal is selectively considered by clinicians, not routinely given. The position paper does not show improved clinical outcomes or establish a universal losartan dosing protocol.

References

  1. Organon LLC. Cozaar (losartan potassium) prescribing information. Revised June 2025, DailyMed entry updated January 20, 2026. Official Cozaar label
  2. Lo MW, et al. Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans. Clinical Pharmacology & Therapeutics. 1995. PubMed
  3. Prasa D, et al. Angiotensin II antagonists: an assessment of their acute toxicity. Clinical Toxicology. 2013. PubMed
  4. Chyka PA, et al. Position paper: Single-dose activated charcoal. Clinical Toxicology. 2005. PubMed
  5. National Capital Poison Center. Poison Control help and emergency guidance. Accessed October 3, 2026. Poison Control
  6. Balit CR, et al. Unintentional paediatric ingestions of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists. Journal of Paediatrics and Child Health. 2007. PubMed
  7. Dreischulte T, et al. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury. Kidney International. 2015. PubMed
  8. Dahlof B, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. The Lancet. 2002. PubMed
Evidence overview for losartan: Losartan Overdose and Accidental Excess Dose: Recognition, Treatment, and Clinical Management